FEATURES - INVESTOR RELATIONS - Merck takes its medicine - The family-controlled German drug giant has its first nonfamily chairman. And for public shareholders, Bernhard Scheuble may be the right potion.
|Year of publication:||
Institutional investor. - New York, NY : Institutional Investor Inc., ISSN 0192-5660, ZDB-ID 3955412. - Vol. 26.2001, 3, p. 27-35
Lanchner, David, (2009)
Lanchner, David, (2008)
EXCHANGES - The lull before reform? - Competitive threats posed by a reconfigured NYSE and Nasdaq, revamped rules and the fallout from Deutsche Börse's aborted bid for the London Stock Exchange could usher in an era of lower costs for European exchange users, and greater profits for bourse investors.
Lanchner, David, (2005)
- More ...